Endodiag is specialized in the development of products and services aimed at improving the diagnosis of endometriosis. With its EndoGram prognosis program, the Company contributes to improving current diagnostic practice by providing additional biological information for a personalized medical and therapeutic management for each patient. In parallel, Endodiag develops a new non-invasive diagnostic test making endometriosis detection much easier and faster. Finally, the Company offers drug testing services to pharmaceutical companies enabling them to make early in-vitro evaluation of drug efficacy of cell lines and patient-derived cell cultures.

Type
Private
HQ
Évry, FR
Founded
2011
Size (employees)
14 (est)+8%
Endodiag was founded in 2011 and is headquartered in Évry, FR
Report incorrect company information

Endodiag Office Locations

Endodiag has an office in Évry
Évry, FR (HQ)
4 Rue Pierre Fontaine
Show all (1)
Report incorrect company information

Endodiag Financials and Metrics

Summary Metrics

Founding Date

2011

Endodiag total Funding

$8.3 m

Endodiag latest funding size

$3.50 m

Time since last funding

4 years ago

Endodiag investors

Endodiag's latest funding round in November 2014 was reported to be $3.5 m. In total, Endodiag has raised $8.3 m
Show all financial metrics
Report incorrect company information

Endodiag Online and Social Media Presence

Embed Graph
Report incorrect company information

Endodiag Company Life and Culture

Report incorrect company information